Bioatla Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.84

+0.49 (+11.26%)

As of May 16, 2:28 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +94.2% upside

Low Target $5.45

Average Target $9.40

High Target $11.97

Current Price $4.84

Current
$4.84

Target
$9.40

$5.45 $9.40 avg $11.97

Scenario Analysis

Bear Case

$5.45

12.6%

Low target

Base Case

$9.40

+94.2%

Avg target

Bull Case

$11.97

+147.3%

High target

Risk/Reward

11.7x

Highly favorable

Price in Context

52-Week High

$71.50

-93.2% from high

52-Week Low

$3.92

+23.5% from low

Target vs 52W High

$9.40

-86.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%